Cerebral Small Vessel Disease Associated With Atrial Fibrillation Among Older Adults: A Population-Based Study

Mozhu Ding1, Rui Wang1,2,3, Grégoria Kalpouzos1

  • 1Aging Research Center, Department of Neurobiology, Care Sciences and Society (M.D., R.W., G.K., E.J.L., Y.L., L.F., C.Q.), Karolinska Institutet, Stockholm University, Sweden.

Stroke
|June 17, 2021
PubMed

Insights

Atrial fibrillation (AF) is linked to faster progression of white matter lesions and brain ventricle enlargement in older adults. This study investigated AF

Area of Science:

  • Neurology
  • Cardiology
  • Geriatrics

Background:

  • Cerebral small vessel disease (CSVD) is a potential mechanism linking atrial fibrillation (AF) and dementia.
  • The association between AF and CSVD markers is not well understood.
  • Older adults are a key demographic for studying neurodegenerative processes.

Purpose of the Study:

  • To investigate the association between atrial fibrillation (AF) and markers of cerebral small vessel disease (CSVD).
  • To examine the progression of CSVD in older adults with and without AF.
  • To understand the role of CSVD in the relationship between AF and cognitive decline.

Main Methods:

  • Cohort study including 336 participants (age ≥60 years) from the Swedish National Study on Aging and Care in Kungsholmen.
  • Brain magnetic resonance imaging (MRI) used to assess CSVD markers: perivascular spaces, lacunes, white matter hyperintensities, and ventricular volumes.
  • Atrial fibrillation (AF) assessed via clinical examination, ECG, and medical records; analyzed using linear mixed-effects models.

Main Results:

  • Prevalent AF (5.4%) and incident AF (5.6%) were identified over a 6-year follow-up.
  • AF was significantly associated with accelerated annual increases in white matter hyperintensities volume (β=0.45) and lateral ventricular volume (β=0.58).
  • No significant association was found between AF and annual changes in perivascular spaces or lacune number.

Conclusions:

  • Atrial fibrillation (AF) is independently associated with accelerated progression of white matter lesions.
  • AF is also linked to ventricular enlargement in older adults, irrespective of cerebral infarcts.
  • These findings highlight the impact of AF on small vessel disease progression in the aging brain.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
62
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
107
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
56
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
123